Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedAdded related topic tags for Rheumatoid arthritis and MedlinePlus Genetics to the page's metadata. Updated the site revision from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThese updates reflect a small normalization of a listed location spelling (Ādaži → Adazi) and a non-clinical update to the ClinicalTrials.gov page software revision (v3.5.2 → v3.5.3).SummaryDifference0.0%

- Check29 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics and updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check36 days agoChange DetectedRheumatoid arthritis and related topics: MedlinePlus Genetics were removed from the page.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics, expanding the related topics section.SummaryDifference0.1%

- Check58 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.